Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Black Americans With HIV-1: A Randomized Phase 3b, Multicenter, Open-Label Study

With the highest rates of HIV/AIDS in the United States, Black Americans are still underrepresented in HIV medical research. SETTING: BRAAVE (NCT03631732) is a randomized, phase 3b, multicenter, open-label US study. METHODS: Adults identifying as Black or African American and virologically suppresse...

Descripción completa

Detalles Bibliográficos
Autores principales: Hagins, Debbie, Kumar, Princy, Saag, Michael, Wurapa, Anson K., Brar, Indira, Berger, Daniel, Osiyemi, Olayemi, Hileman, Corrilynn O., Ramgopal, Moti N., McDonald, Cheryl, Blair, Christiana, Andreatta, Kristen, Collins, Sean E., Brainard, Diana M., Martin, Hal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JAIDS Journal of Acquired Immune Deficiency Syndromes 2021
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8357046/
https://www.ncbi.nlm.nih.gov/pubmed/34397746
http://dx.doi.org/10.1097/QAI.0000000000002731

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8357046/
https://www.ncbi.nlm.nih.gov/pubmed/34397746
http://dx.doi.org/10.1097/QAI.0000000000002731

Ejemplares similares